Heparin-induced thrombocytopenia: Diagnostic tests and biological mechanisms

Bailliere's Clinical Haematology

Volumn 11, Issue 2, 1998, Pages 447-460

  Amiral, J ^a   Meyer, D ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Antibodies; Complexes; Heparin; Mechanisms; Platelet factor 4; Thrombocytopenia; Thrombosis

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4;

ARTICLE; DIAGNOSTIC TEST; HEALTH STATUS; HEPARINIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; PATHOGENICITY; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA;

EID: 0032417169     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(98)80060-7     Document Type: Article

References (73)

1. Amiral J Bridey F Dreyfus M Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia Thrombosis and Haemostasis 68 1992 95 96
2. Amiral J Bridey F Wolf M Antibodies to macromolecular platelet factor 4 heparin complexes in heparin induced thrombocytopenia: a study of 44 cases Thrombosis and Haemostasis 73 1995 21 28
3. Amiral J Marfaing-Koka A Wolf M Presence of auto-antibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia Blood 88 1996 410 416
4. Amiral J Peynaud-Debayle E Wolf M Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low molecular weight heparin American Journal of Hematology 52 1996 90 95
5. Amiral J Wolf M Fischer AM Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia British Journal of Haematology 92 1996 954 959
6. Amiral J Lormeau JC Marfaing-Koka A Absence of cross-reactivity of SR 90107A/ORG 31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia Blood Coagulation and Fibrinolysis 8 1997 114 117
7. Anderson CL Chacko GW Osborne JM Brandt JT The Fc receptor for immunoglobulin G (FcγRII) on human platelets Seminars in Thrombosis and Hemostasis 21 1995 1 9
8. Arepally G Poncz M McKenzie SE Cines D Characterization of antibody subclass specificity and antigenic determinants in heparin-associated thrombocytopenia (HAT) Blood 84 1994 189a
9. Arepally G Reynolds C Tomaski A Comparison of PF4/heparin ELISA assay with 14C-serotonin release assay in the diagnosis of heparin induced thrombocytopenia American Journal of Clinical Pathology 104 1995 648 654
10. 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis Blood 89 1997 370 375
11. Aziz KA Cawley JC Zulel M Platelets prime PMN via released PF4: mechanism of priming and synergy with GM-CSF British Journal of Haematology 91 1995 846 853
12. Bauer TL Arepally G Konkle BA Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242 1246
13. Boshkov LK Warkentin TE Hayward CPM Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies British Journal of Haematology 84 1993 322 328
14. Brandt E Flad HD Structure and function of platelet-derived cytokines of the β-thromboglobulin/interleukin 8 family Platelets 3 1992 295 305
15. Brandt J Isenhgart CE Osborne JM On the role of platelet FcγRIIa phenotype in heparin-induced thrombocytopenia Thrombosis and Haemostasis 74 1995 1564 1572
16. Burgess JK Lindeman R Chesterman CN Chong BH Single amino acid mutation of Fcγ receptor is associated with the development of heparin-induced thrombocytopenia British Journal of Haematology 91 1995 761 766
17. Cadroy Y Amiral J Raynaud H Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin induced thrombocytopenia reexposed to heparin Thrombosis and Haemostasis 72 1994 782 786
18. Capitanio AM Niewiarowski S Rucinski B Interaction of platelet factor 4 with human platelets Biochimica et Biophysica Acta 839 1985 161 173
19. St Charles R Walz DA Edwards FP The three-dimensional structure of bovine platelet factor 4 at 3.0-Å resolution Journal of Biological Chemistry 264 1989 2092 2099
20. Chignard M Renesto P Proteinases and cytokines in neutrophil and platelet interactions in vitro. Possible relevance to the adult respiratory distress syndrome Annals of the New York Academy of Sciences 725 1994 309 322
21. Chong BH Ismail F Cade J Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 Blood 73 1989 1592 1596
22. Chong BH Burgess J Ismail F The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia Thrombosis and Haemostasis 69 1993 344 350
23. Chong BH Pilgrim RL Cooley MA Chesterman CN Increased expression of platelet IgG Fc receptors in immune heparin induced thrombocytopenia Blood 81 1993 988 993
24. Cines DB Tomaski A Tannenbaum S Immune endothelial-cell injury in heparin-associated thrombocytopenia New England Journal of Medicine 316 1987 581 589
25. Cowan SW Bakshi EN Machin KJ Isaacs NW Binding of heparin to human platelet factor 4 Biochemical Journal 234 1986 485 488
26. Fiessinger JN Aiach M Roncato M Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase Thrombosis Research 33 1984 235 238
27. Fratantoni JC Pollet R Gralnick HR Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods Blood 45 1975 395 401
28. Greinacher A Michels I Kiefel V Mueller-Eckhardt C A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia Thrombosis and Haemostasis 66 1991 734 736
29. Greinacher A Amiral J Dummel V Laboratory diagnosis of heparin associated thrombocytopenia and comparison of platelet aggregation test, heparin induced platelet activation test, and platelet factor 4/heparin enzyme linked immunosorbent assay Transfusion 34 1994 381 385
30. Greinacher A Liebenhoff U Kiefel V Heparin associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation: a possible new indication for high dose I.V. IgG Thrombosis and Haemostasis 71 1994 641 645
31. Greinacher A Pötzch B Amiral J Heparin associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular pF4-Heparin complex as the major antigen Thrombosis and Haemostasis 71 1994 247 251
32. Greinacher A Alban S Dummel V Characterization of the structural requirements for a carbonhydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thromboctopenia Thrombosis and Haemostasis 74 1995 886 892
33. Gruel Y Boizard-Boval B Wautier JL Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia Thrombosis and Haemostasis 70 1993 375
34. Gruel Y Lermusiaux P Lang M Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis Annals of Vascular Surgery 5 1991 552 555
35. Hach-Wunderle V Kainer K Krug B Heparin-associated thrombosis despite normal platelet counts Lancet 344 1994 469 470
36. Harenberg J Malsch R Piazolo L Heene DL Binding of heparin to human leukocytes Hämostaseologie 14 1994 16 24
37. Horne McDK III Chao ES The effect of molecular weight on heparin binding to platelets British Journal of Haematology 74 1990 306 312
38. Huang SS Huang JS Deuel TF Proteoglycan carrier of human platelet factor 4 Journal of Biological Chemistry 257 1982 11 546 11 550
39. Huisse MC Guillin MC Bezeaud Z Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions Thrombosis Research 27 1982 485 490
40. Kelton J Pathophysiology of heparin-induced thrombocytopenia British Journal of Haematology 82 1992 778 784
41. Kelton JG Sheridan D Santos A Heparin induced thrombocytopenia: laboratory studies Blood 72 1988 925 930
42. Kelton G Smith JW Warkentin TE Immunoglobulin G from patients with heparin induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232 3239
43. Kolset SO Mann DM Uhlin-Hansen L Serglycin-binding proteins in activated macrophages and platelets Journal of Leucocyte Biology 59 1996 545 554
44. Laroche J Clofent-Sanchez G Jallu V Further evidence that heparin dependent thrombocytopenia may result from Fc receptor-mediated interactions Nouvelle Revue Française d'Hematologie 34 1992 111 121
45. Lecompte T Stieltjes N Shao-kai L Heparin and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis Seminars in Thrombosis and Hemostasis 21 1995 95 105
46. Lecrubier C Lecompte T Potevin F Tests d'agrégation plaquettaire dans 26 cas de thrombopénies induites par l'héparine (TIH) Journal des Maladies Vasculaires 12 1987 128 132
47. Lee DH Warkentin TE Denomme GA A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry British Journal of Haematology 95 1996 724 731
48. Maccarana M Lindahl U Mode of interaction between platelet factor 4 and heparin Glycobiology 3 1993 271 277
49. Magnani HN Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172) Thrombosis and Haemostasis 70 1993 554 561
50. Marcus AJ Safier LB Broekman MJ Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions Thrombosis and Haemostasis 74 1995 213 217
51. Mayo KH Chen MJ Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by H NMR spectroscopy Biochemistry 28 1989 9469 9478
52. Petersen F Lidwig A Flad HD Brandt E TNF-α renders human neutrophils responsive to platelet factor 4 Journal of Immunology 156 1996 1954 1962
53. Pouplard C Amiral J Borg JY Differences in specificity of heparin-dependent antibodies developed under low-molecular-weight-heparin therapy and higher cross-reactivity with Orgaran British Journal of Haematology 99 1997 273 280
54. Reininger CB Greinacher A Graf J Platelets of patients with peripheral arterial disease are hypersensitive to heparin Thrombosis Research 81 1996 641 649
55. Rhodes GR Dixon RH Sylver D Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations Surgery Gynecology Obstetrica 136 1973 409 416
56. van Rijn JLML Trillou M Mardiguian J Selective binding of heparins to human endothelial cells. Implications for pharmacokinetics Thrombosis Research 45 1987 211 222
57. Rybak ME Gimbrone MA Davies PF Handin RI Interaction of platelet factor four with cultured vascular endothelial cells Blood 73 1989 1534 1539
58. Sheridan D Carter C Kelton JG A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
59. Sobel M Adelman B Characterization of platelet binding of heparins and other glycosaminoglycans Thrombosis Research 50 1988 815 826
60. Stewart MW Etches WS Boshkov LK Gordon PA Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry British Journal of Haematology 91 1995 173 177
61. Stuckey JA St Charles R Edwards B A model of the platelet factor 4 complex with heparin Proteins 14 1992 277 287
62. Suh J-S Malik M-I Aster R-H Visentin G-P Characterization of the humoral immune response in heparin-induced thrombocytopenia American Journal of Hematology 54 1997 196 201
63. Tanaka Y Adams DH Shaw S Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes Immunology Today 14 1993 111 115
64. Teitel JM Gross P Blake P Garvey MB A bioluminescent adenosine nucléotide release assay for the diagnosis of heparin-induced thrombocytopenia Thrombosis and Haemostasis 73 1996 479
65. Tomer A A sensitive and specific functional flow cytometric assay for the diagnosis of heparin induced thrombocytopenia British Journal of Haematology 98 1997 648 656
66. Towne JB Bernhard VM Hussey C Garancis JC White clot syndrome Archives of Surgery 114 1979 272 277
67. Visentin GP Aster RH Heparin induced thrombocytopenia and thrombosis Current Opinion in Hematology 2 1995 351 357
68. Visentin GP Ford SE Scott JP Aster RH Antibodies from patients with heparin induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells Journal of Clinical Investigation 93 1994 81 88
69. Visentin GP Malik M Cyganiak KA Aster RH Patients with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes Journal of Laboratory and Clinical Medicine 128 1996 376 383
70. Walz DA Wu VY de Lamo R Primary structure of human platelet factor 4 Thrombosis Research 11 1977 893 898
71. Warkentin TE Kelton JG A 14-year study of heparin-induced thrombocytopenia American Journal of Medicine 101 1996 502 507
72. Warkentin TE Levine MN Hirsh J Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin New England Journal of Medicine 332 1995 1330 1335
73. (abstract) Warkentin TE Russet JI Johnston M Kelton JG Warfarin treatment of deep vein thrombosis complicating heparin-induced thrombocytopenia (HIT) is a risk factor for initiation of venous limb gangrene: report of nine patients implicating the interacting procoagulant effects of two anticoagulant agents Thrombosis and Haemostasis 73 1995 804